|
Website:
http://www.novartis.com
Phone: +41 61 324 1111 |
Address:
CH-4002 Basel
4002 Basel, |
Company Description
Novartis AG. The Group's principal activity is the development and manufacture of pharmaceuticals and nutritional products. The Group operates through four divisions; Pharmaceuticals, Consumer Health, Sandoz & Vaccines & Diagnostics. Pharmaceuticals Division includes drugs for use in transplantations, central nervous system disorders, cardiovascular, endocrine and respiratory diseases, dermatology, oncology, hematology and rheumatism and bone and hormone replacement therapy. Consumer Health Division includes Generics/OTC and sells copies of prescription medicines no longer under patent protection; medical nutrition and self-medication. Sandoz Division: Manufactures, distributes and sells generic pharmaceutical products and substances no longer subject to patent protection. Vaccines & Diagnostics Division provides innovative vaccines and a range of conventional products to combat viral and bacterial diseases. In 2006, the Group acquired Chiron Corporation & NeuTec Pharma plc. Pharmaceuticals accounted for 63% of 2006 revenues, Consumer Health, 18%, Sandoz, 17% & Vaccines & Diagnostics, 2%
Key People
| Chairman, President & Chief Executive | Dr. Daniel Vasella |
| Chief Financial Officer | Raymund Breu |
| Vice Chairman | Prof. Ulrich Lehner |
| Vice Chairman | Hans-Joerg Rudloff |
| Secretary | Monika Matti |
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
N
Novartis AG
Discovers, develops, manufactures and markets arthritis, inflammation, bone, cardiovascular, metabolic, dermatology, hematology, neuroscience, and oncology drugs.
www.novartis.com
Discovers, develops, manufactures and markets arthritis, inflammation, bone, cardiovascular, metabolic, dermatology, hematology, neuroscience, and oncology drugs.
www.novartis.com
Breaking News
Forbes.com - 5 hours ago
PHILADELPHIA, July 9 (Reuters) - The second round of bids for the animal health businesses being divested by Merck & Co Inc and Schering Plough Corp are due next week with a final decision expected by the end of July, sources familiar with the situation ...
Forbes.com - 10 hours ago
ZURICH, July 8 (Reuters) - Novartis AG's Rasilez pill has been approved to treat high blood pressure in Japan, the Swiss drugmaker said on Wednesday. The country's Ministry of Health, Labour and Welfare (MHLW) approved Rasilez to treat the condition ...
Reuters - 10 hours ago
(Corrects last paragraph to show Rasilez' patent protection expires in 2018 in the United States and 2020 in Europe and Japan, not in 2012) * Japanese approve drug to treat high blood pressure * Is approved in over 70 countries (Adds details, background) ...
Forbes.com - 11 hours ago
Does the same biology that leads cancer cells to run amok also cause us to age? New research published in the journal Nature begs that question. Mice who were fed the transplant drug Rapamune late in their lives lived longer than mice in a control group. ...
Forbes.com via MSN Money - 12 hours ago
A 10-year-old drug seems to slow aging, raising enticing questions about cancer and immunity. Does the same biology that leads cancer cells to run amok also cause us to age? New research published in the journal Nature begs that question. Mice who were ...
Find Free Prescriptions
Prescription Assistance Programs Annual Income under $42k to Join
www.myrxadvocate.com
Prescription Assistance Programs Annual Income under $42k to Join
www.myrxadvocate.com
Pfizer Pharmaceutical
Morningstar provides a Free Report: "Healthcare Sector and the Economy"
healthcare.morningstar.com
Morningstar provides a Free Report: "Healthcare Sector and the Economy"
healthcare.morningstar.com
